ロード中...
Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder
Mithramycin (MTR) is a clinically approved DNA-binding antitumor antibiotic currently in Phase 2 clinical trials at National Institutes of Health for treatment of osteosarcoma. In view of the resurgence in the studies of this generic antibiotic as a human medicine, we have examined the binding prope...
保存先:
| 出版年: | FEBS Open Bio |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4247356/ https://ncbi.nlm.nih.gov/pubmed/25473595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.fob.2014.10.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|